Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-03 Sale | 2024-01-05 4:46 pm | Intellia Therapeutics Inc. | NTLA | Hicks Derek EVP, Chief Business Officer | 3,877 | $29.46 | $114,216 | 36,987 (Direct) | View |
| 2023-01-04 Sale | 2023-01-06 5:29 pm | Intellia Therapeutics Inc. | NTLA | Hicks Derek EVP, Chief Business Officer | 1,812 | $37.21 | $67,425 | 17,306 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-05 4:10 pm | N/A 2034-02-28 | Intellia Therapeutics Inc. | NTLA | Hicks Derek EVP, Chief Business Officer | 71,814 | $0 | 108,801 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:31 pm | N/A 2033-02-28 | Intellia Therapeutics Inc. | NTLA | Hicks Derek EVP, Chief Business Officer | 56,845 | $0 | 74,151 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:15 pm | N/A 2032-01-02 | Intellia Therapeutics Inc. | NTLA | Hicks Derek EVP, Chief Business Officer | 44,118 | $0 | 44,118 (Direct) | View |